Home / Stocks / RARE

RARE insider trading

Ultragenyx Pharmaceutical Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-03KAKKIS EMIL D
President & CEO
Sold54,404$22.80$1.2M
2025-03-04KAKKIS EMIL D
President & CEO
Sold98,434$42.20$4.2M
2024-09-05KAKKIS EMIL D
President & CEO
Sold20,000$55.85$1.1M

See RARE on the chart

Every insider buy and sell for RARE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.